Analysis of tumour size by ultrasound confirmed a robust tumour shrinkage in response to BAY 1895344 treatment at day 3 in both Rosa26_Alkal2;Th-MYCN and Alk-F1178S;Th-MYCN tumours (Fig. 6d). Here, ALK is linked to neoplasm.